š”š²šš š¦ššŗšŗš®šæš
ā¢ Sun Pharma reported a 5% YoY jump in net profit to Rs 2376 crore in Q2FY24, with broad-based sales growth across markets.
ā¢ The company's India formulation sales rose 11.1% YoY to Rs. 3843 crore, accounting for 32% of Sun Pharma's sales.
ā¢ Sun Pharma's R&D expenses rose 36% YoY to Rs 773 crore as the company continues to invest in building its pipeline for various markets.